How do we answer that? One way is to look at which one is more likely to kill you. We do that by analyzing what is called the hazard ratio. It measures your likelihood of dying compared to the average person.
You can see by the chart that during the progression from stage 2 to stage 3 fibrosis, a liver patient is twice as likely to die as a patient with type 2 diabetes.
During this period there are probably NO symptoms to indicate that your liver is sick. That kind of sucks since 30% of us have a liver disease.
As a society we test and intervene for diabetes but not for advancing NASH even though the risk of death is higher for liver disease.
These grim statistics are why we advocate for wellness screening for the detection of advancing liver disease that has no symptoms.